AbbVie lifts 2026 EPS guidance, closes Apogee deal, posts Skyrizi and Juvmo approvalsNov 12M&AAbbVieBiovie Inc.Updated
Indivior reports record SUBLOCADE revenue ahead of Supernus merger closeOct 29Quarterly updatebuprenorphineIndivior Pharmaceuticals, Inc.
Indivior supplements proxy disclosures for Supernus merger ahead of October 15 voteOct 6M&AIndivior Pharmaceuticals, Inc.
Indivior declares $8.13 per share special dividend tied to Supernus merger closingSep 17M&AIndivior Pharmaceuticals, Inc.
Indivior and Reckitt Benckiser move up end date of Suboxone/Subutex supply dealSep 15Partnershipbuprenorphine hydrochloride, naloxone hydrochlorideIndivior Pharmaceuticals, Inc.
Indivior raises 2026 guidance on record SUBLOCADE revenueAug 3Quarterly updatebuprenorphineIndivior Pharmaceuticals, Inc.
Indivior and Supernus agree to merge, forming Supernus, Inc.Aug 3PartnershipIndivior Pharmaceuticals, Inc.